Physiol Rev Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Physiol. Rev. 77: 517-544, 1997;
0031-9333/97 $15.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lieber, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lieber, C. S.

Physiological Reviews, Vol 77, 517-544, Copyright © 1997 by American Physiological Society

JOURNAL ARTICLE

Cytochrome P-4502E1: its physiological and pathological role

C. S. Lieber
Alcohol Research and Treatment Center, Bronx Department of Veterans Affairs Medical Center, New York, USA.

The role of the microsomal ethanol-oxidizing system (MEOS) in hepatic ethanol metabolism is reviewed, with focus on its constitutive, ethanol-inducible cytochrome P-4502E1 (2E1). The MEOS was purified and reconstituted using 2E1, phospholipids, and cytochrome P-450 reductase and shown to oxidize ethanol to acetaldehyde, mainly as a monooxygenase and secondarily via hydroxyl radicals, with transcriptional and posttranscriptional regulation. Polymorphism of 2E1 was recognized, and enzymology (including cofactors, role of lipids, inducers, and inhibitors) as well as cellular and tissue distribution were chartered. Physiological functions involve lipid metabolism and ketone utilization in starvation, obesity, and diabetes. The most significant role of 2E1 is its adaptive response to high blood ethanol levels with a corresponding acceleration of ethanol metabolism. The associated free radical production, however, contributes to liver injury in the alcoholic. Most importantly, 2E1 has a unique capacity to activate many xenobiotics (85 of which are listed) to hepatotoxic or carcinogenic products. Induction of 2E1 also results in enhanced production of acetaldehyde, a highly reactive and toxic metabolite. The proliferation of the endoplasmic reticulum associated with 2E1 induction is also accompanied by enhanced activity of other cytochrome P-450s, resulting in accelerated metabolism of, and tolerance to, other drugs, as well as increased degradation of retinol and its hepatic depletion. Some substrates and metabolites, however, are innocuous and may eventually be used as markers of heavy drinking. Recently discovered effective 2E1 inhibitors also have great therapeutic potential.


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Morita, L. Le Marchand, S. Kono, G. Yin, K. Toyomura, J. Nagano, T. Mizoue, R. Mibu, M. Tanaka, Y. Kakeji, et al.
Genetic Polymorphisms of CYP2E1 and Risk of Colorectal Cancer: The Fukuoka Colorectal Cancer Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 235 - 241.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. Cheung and F. J. Gonzalez
Humanized Mouse Lines and Their Application for Prediction of Human Drug Metabolism and Toxicological Risk Assessment
J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 288 - 299.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
N. Anderson and J. Borlak
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Morita, S. Tabata, O. Tajima, G. Yin, H. Abe, and S. Kono
Genetic Polymorphisms of CYP2E1 and Risk of Colorectal Adenomas in the Self Defense Forces Health Study
Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1800 - 1807.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
C. Y. Ahn, S. K. Bae, Y. S. Jung, I. Lee, Y. C. Kim, M. G. Lee, and W. G. Shin
Pharmacokinetic Parameters of Chlorzoxazone and Its Main Metabolite, 6-Hydroxychlorzoxazone, after Intravenous and Oral Administration of Chlorzoxazone to Liver Cirrhotic Rats with Diabetes Mellitus
Drug Metab. Dispos., July 1, 2008; 36(7): 1233 - 1241.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Chen, K. W. Krausz, J. R. Idle, and F. J. Gonzalez
Identification of Novel Toxicity-associated Metabolites by Metabolomics and Mass Isotopomer Analysis of Acetaminophen Metabolism in Wild-type and Cyp2e1-null Mice
J. Biol. Chem., February 22, 2008; 283(8): 4543 - 4559.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Dey and A. I. Cederbaum
Geldanamycin, an Inhibitor of Hsp90, Potentiates Cytochrome P4502E1-Mediated Toxicity in HepG2 Cells
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1391 - 1399.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. Bai and A. I. Cederbaum
Adenovirus-Mediated Expression of CYP2E1 Produces Liver Toxicity in Mice
Toxicol. Sci., June 1, 2006; 91(2): 365 - 371.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. Joshi and R. F. Tyndale
INDUCTION AND RECOVERY TIME COURSE OF RAT BRAIN CYP2E1 AFTER NICOTINE TREATMENT
Drug Metab. Dispos., April 1, 2006; 34(4): 647 - 652.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Bai and A. I. Cederbaum
Overexpression of CYP2E1 in Mitochondria Sensitizes HepG2 Cells to the Toxicity Caused by Depletion of Glutathione
J. Biol. Chem., February 24, 2006; 281(8): 5128 - 5136.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
Y. Lu and A. I. Cederbaum
Cisplatin-Induced Hepatotoxicity Is Enhanced by Elevated Expression of Cytochrome P450 2E1
Toxicol. Sci., February 1, 2006; 89(2): 515 - 523.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
J.-Y. Park, K.-A. Kim, P.-W. Park, and J.-M. Ha
Effect of High-Dose Aspirin on CYP2E1 Activity in Healthy Subjects Measured Using Chlorzoxazone as a Probe
J. Clin. Pharmacol., January 1, 2006; 46(1): 109 - 114.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. Chilakapati, K. Shankar, M. C. Korrapati, R. A. Hill, and H. M. Mehendale
SATURATION TOXICOKINETICS OF THIOACETAMIDE: ROLE IN INITIATION OF LIVER INJURY
Drug Metab. Dispos., December 1, 2005; 33(12): 1877 - 1885.
[Abstract] [Full Text] [PDF]

Home page
 J DAIRY SCIHome page
K. A. Kruger, J. W. Blum, and D. L. Greger
Expression of Nuclear Receptor and Target Genes in Liver and Intestine of Neonatal Calves Fed Colostrum and Vitamin A
J Dairy Sci, November 1, 2005; 88(11): 3971 - 3981.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
P. Soucek, P. Anzenbacher, I. Skoumalova, and M. Dvorak
Expression of Cytochrome P450 Genes in CD34+ Hematopoietic Stem and Progenitor Cells
Stem Cells, September 1, 2005; 23(9): 1417 - 1422.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. Baranova, E. Anzenbacherova, P. Anzenbacher, and P. Soucek
MINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYME
Drug Metab. Dispos., June 1, 2005; 33(6): 862 - 865.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
Y. XU, M. A. LEO, and C. S. LIEBER
DLPC ATTENUATES ALCOHOL-INDUCED CYTOTOXICITY IN HEPG2 CELLS EXPRESSING CYP2E1
Alcohol Alcohol., May 1, 2005; 40(3): 172 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
C. Cheung, A.-M. Yu, J. M. Ward, K. W. Krausz, T. E. Akiyama, L. Feigenbaum, and F. J. Gonzalez
THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
Drug Metab. Dispos., March 1, 2005; 33(3): 449 - 457.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
G. Iohom, D. Fitzgerald, and A. J. Cunningham
Principles of pharmacogenetics--implications for the anaesthetist
Br. J. Anaesth., September 1, 2004; 93(3): 440 - 450.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
C. S Lieber, M. A Leo, K. M Mak, Y. Xu, Q. Cao, C. Ren, A. Ponomarenko, and L. M DeCarli
Model of nonalcoholic steatohepatitis
Am. J. Clinical Nutrition, March 1, 2004; 79(3): 502 - 509.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
L. G. Sultatos, G. M. Pastino, C. A. Rosenfeld, and E. J. Flynn
Incorporation of the Genetic Control of Alcohol Dehydrogenase into a Physiologically Based Pharmacokinetic Model for Ethanol in Humans
Toxicol. Sci., March 1, 2004; 78(1): 20 - 31.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Raza, S. K. Prabu, M.-A. Robin, and N. G. Avadhani
Elevated Mitochondrial Cytochrome P450 2E1 and Glutathione S-Transferase A4-4 in Streptozotocin-Induced Diabetic Rats: Tissue-Specific Variations and Roles in Oxidative Stress
Diabetes, January 1, 2004; 53(1): 185 - 194.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
C. Handschin and U. A. Meyer
Induction of Drug Metabolism: The Role of Nuclear Receptors
Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. Seth, M. A. Leo, P. H. McGuinness, C. S. Lieber, Y. Brennan, R. Williams, X. M. Wang, G. W. McCaughan, M. D. Gorrell, and P. S. Haber
Gene Expression Profiling of Alcoholic Liver Disease in the Baboon (Papio hamadryas) and Human Liver
Am. J. Pathol., December 1, 2003; 163(6): 2303 - 2317.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. L. Micu, S. Miksys, E. M. Sellers, D. R. Koop, and R. F. Tyndale
Rat Hepatic CYP2E1 Is Induced by Very Low Nicotine Doses: An Investigation of Induction, Time Course, Dose Response, and Mechanism
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 941 - 947.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Moncion, N. T. Truong, A. Garrone, P. Beaune, R. Barouki, and I. de Waziers
Identification of a 16-Nucleotide Sequence That Mediates Post-transcriptional Regulation of Rat CYP2E1 by Insulin
J. Biol. Chem., November 22, 2002; 277(48): 45904 - 45910.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
C. S Lieber
S-Adenosyl-L-methionine: its role in the treatment of liver disorders
Am. J. Clinical Nutrition, November 1, 2002; 76 (5): 1183S - 1187S.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
C. Lejus, C. Le Roux, E. Legendre, M. Renaudin, H. L. Boiteau, and M. Pinaud
Fluoride excretion in children after sevoflurane anaesthesia
Br. J. Anaesth., November 1, 2002; 89(5): 693 - 696.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
F. R. Simon, J. Fortune, M. Iwahashi, and E. Sutherland
Sexual dimorphic expression of ADH in rat liver: importance of the hypothalamic-pituitary-liver axis
Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G646 - G655.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
H. Fisher, A. Halladay, N. Ramasubramaniam, J. C. Petrucci, D. Dagounis, A. Sekowski, J. V. Martin, and G. C. Wagner
Liver Fat and Plasma Ethanol Are Sharply Lower in Rats Fed Ethanol in Conjunction with High Carbohydrate Compared with High Fat Diets
J. Nutr., September 1, 2002; 132(9): 2732 - 2736.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. C. Chung, S. H. Kim, M. G. Lee, and S. G. Kim
Increase in Urea in Conjunction with L-Arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): The Role of Urea in CYP2E1 Induction by Acute Renal Failure
Drug Metab. Dispos., June 1, 2002; 30(6): 739 - 746.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Mari, J. Bai, and A. I. Cederbaum
Adenovirus-Mediated Overexpression of Catalase in the Cytosolic or Mitochondrial Compartment Protects against Toxicity Caused by Glutathione Depletion in HepG2 Cells Expressing CYP2E1
J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 111 - 118.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
Z. Zhou, X. Sun, and Y. James Kang
Metallothionein Protection against Alcoholic Liver Injury through Inhibition of Oxidative Stress
Experimental Biology and Medicine, March 1, 2002; 227(3): 214 - 222.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. M. MATO, F. J. CORRALES, S. C. LU, and M. A. AVILA
S-Adenosylmethionine: a control switch that regulates liver function
FASEB J, January 1, 2002; 16(1): 15 - 26.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. A. Howard, A. L. Micu, E. M. Sellers, and R. F. Tyndale
Low Doses of Nicotine and Ethanol Induce CYP2E1 and Chlorzoxazone Metabolism in Rat Liver
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 542 - 550.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. A. Nanji, K. Jokelainen, G. L. Tipoe, A. Rahemtulla, and A. J. Dannenberg
Dietary Saturated Fatty Acids Reverse Inflammatory and Fibrotic Changes in Rat Liver Despite Continued Ethanol Administration
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 638 - 644.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. M. Fontaine, P. B. Hoyer, J. R. Halpert, and I. G. Sipes
Role of Induction of Specific Hepatic Cytochrome P450 Isoforms in Epoxidation of 4-Vinylcyclohexene
Drug Metab. Dispos., September 1, 2001; 29(9): 1236 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. S. Sidhu, F. Liu, S. M. Boyle, and C. J. Omiecinski
PI3K Inhibitors Reverse the Suppressive Actions of Insulin on CYP2E1 Expression by Activating Stress-Response Pathways in Primary Rat Hepatocytes
Mol. Pharmacol., April 16, 2001; 59(5): 1138 - 1146.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
H. C. Chung, S. H. Sung, J. S. Kim, Y. C. Kim, and S. G. Kim
Lack of Cytochrome P450 2E1 (CYP2E1) Induction in the Rat Liver by Starvation without Coprophagy
Drug Metab. Dispos., March 1, 2001; 29(3): 213 - 216.
[Abstract] [Full Text]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
T. R. Fennell, J. P. MacNeela, R. W. Morris, M. Watson, C. L. Thompson, and D. A. Bell
Hemoglobin Adducts from Acrylonitrile and Ethylene Oxide in Cigarette Smokers: Effects of Glutathione S-Transferase T1-Null and M1-Null Genotypes
Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 705 - 712.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
S. S. Percival and C. A. Sims
Wine Modifies the Effects of Alcohol on Immune Cells of Mice1-3
J. Nutr., May 1, 2000; 130(5): 1091 - 1094.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
A. Banerjee, T. A. Kocarek, and R. F. Novak
Identification of a Ubiquitination-Target/Substrate-Interaction Domain of Cytochrome P-450 (CYP) 2E1
Drug Metab. Dispos., February 1, 2000; 28(2): 118 - 124.
[Abstract] [Full Text]

Home page
 Alcohol AlcoholHome page
M. D. J. Kerai, C. J. Waterfield, S. H. Kenyon, D. S. Asker, and J. A. Timbrell
REVERSAL OF ETHANOL-INDUCED HEPATIC STEATOSIS AND LIPID PEROXIDATION BY TAURINE: A STUDY IN RATS
Alcohol Alcohol., July 1, 1999; 34(4): 529 - 541.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
A. M. Watson, S. M. Poloyac, G. Howard, and R. A. Blouin
Effect of Leptin on Cytochrome P-450, Conjugation, and Antioxidant Enzymes in the ob/ob Mouse
Drug Metab. Dispos., June 1, 1999; 27(6): 695 - 700.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
E. D. Kharasch, D. C. Hankins, C. Jubert, K. E. Thummel, and J. K. Taraday
Lack of Single-Dose Disulfiram Effects on Cytochrome P-450 2C9, 2C19, 2D6, and 3A4 Activities: Evidence for Specificity Toward P-450 2E1
Drug Metab. Dispos., June 1, 1999; 27(6): 717 - 723.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. R. Brzezinski, H. Boutelet-Bochan, R. E. Person, A. G. Fantel, and M. R. Juchau
Catalytic Activity and Quantitation of Cytochrome P-450 2E1 in Prenatal Human Brain
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1648 - 1653.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
J.-Y. Huan and D. R. Koop
Tightly Regulated and Inducible Expression of Rabbit Cyp2e1 Using A Tetracycline-Controlled Expression System
Drug Metab. Dispos., April 1, 1999; 27(4): 549 - 554.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
K. Sakurai and A. I. Cederbaum
Oxidative Stress and Cytotoxicity Induced by Ferric-Nitrilotriacetate in HepG2 Cells That Express Cytochrome P450 2E1
Mol. Pharmacol., December 1, 1998; 54(6): 1024 - 1035.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
N. Nieto, P. Greenwel, S. L. Friedman, F. Zhang, A. J. Dannenberg, and A. I. Cederbaum
Ethanol and Arachidonic Acid Increase alpha 2(I) Collagen Expression in Rat Hepatic Stellate Cells Overexpressing Cytochrome P450 2E1. ROLE OF H2O2 AND CYCLOOXYGENASE-2
J. Biol. Chem., June 23, 2000; 275(26): 20136 - 20145.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Mari and A. I. Cederbaum
CYP2E1 Overexpression in HepG2 Cells Induces Glutathione Synthesis by Transcriptional Activation of gamma -Glutamylcysteine Synthetase
J. Biol. Chem., May 12, 2000; 275(20): 15563 - 15571.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online